Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, EBITDA Accretion and Cashflow GenerationDUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a ...
A well-recognized pharmaceutical industry executive, Mr. Evangelista brings over 30 years of strategic leadership and operational expertise to Trinity, having previously served in consulting, CRO, and ...
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic ...
Trinity Biotech (TRIB) announced a strategic collaboration with a leading bioinformatics company to conduct advanced analysis on clinical trial ...